The U.S. Food and Drug Administration approved today the use of Vascepa icosapent ethyl, supporting therapy to reduce the risk of cardiovascular disease for adults with high triglyceride levels. FDA…
The U.S. Food and Drug Administration approved today the use of Vascepa icosapent ethyl, supporting therapy to reduce the risk of cardiovascular disease for adults with high triglyceride levels. FDA…
By Richelle Ann Agpoon December 21, 2019